Traws Pharma
(NASDAQ) TRAW
Traws Pharma Financials at a Glance
Market Cap
$28.50M
Revenue (TTM)
$2.79M
Net Income (TTM)
$23.94M
EPS (TTM)
$-2.27
P/E Ratio
1.37
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$1.89
Volume
17,507
Open
$1.55
Price
$1.89
Volume
17,507
Open
$1.55
Previous Close
$1.88
Daily Range
$1.55 - $1.95
52-Week Range
$0.99 - $3.27
Dividend
$0.00
Beta (Volatility)
1.07 (Average)
Price
$1.89
Volume
17,507
Open
$1.55
Previous Close
$1.88
Daily Range
$1.55 - $1.95
52-Week Range
$0.99 - $3.27
TRAW News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Traws Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Iain David Dukes, PhD
Website
www.trawspharma.comHeadquarters
Newtown, PA 18940, US
TRAW Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-5639%
Return on Capital
1376%
Return on Assets
-2%
Earnings Yield
72.99%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$28.50M
Shares Outstanding
15.16M
Volume
17.51K
Avg. Volume
2.09M
Financials (TTM)
Gross Profit
$2.79M
Operating Income
$17.88M
EBITDA
$17.81M
Operating Cash Flow
$18.18M
Capital Expenditure
$2.58M
Free Cash Flow
$20.77M
Cash & ST Invst.
$3.82M
Total Debt
$0.00
Traws Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$28.50M
N/A
Market Cap/Employee
$4.75M
N/A
Employees
6
N/A
Net Income
$7.11M
-42.6%
EBITDA
$6.95M
-33.4%
Quarterly Fundamentals
Net Cash
$3.13M
-81.4%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-1.78%
N/A
Return on Invested Capital
1376.36%
N/A
Free Cash Flow
$2.58B
-26047.0%
Operating Cash Flow
$2.58B
-26047.0%